Engrail Therapeutics
Engrail Therapeutics is a clinical-stage pharmaceutical company focused on developing transformative therapies for neuropsychiatric and neurodevelopmental disorders. They are advancing a pipeline of treatments for conditions such as anxiety disorders, depression, and rare neurodegenerative diseases, addressing significant unmet medical needs.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $157M
Date: 19-Mar-2024
Investors: F-Prime Capital, Forbion, Norwest Venture Partners, RiverVest Venture Partners, Red Tree Venture Capital, funds managed by abrdn Inc., Ysios Capital, Longwood Fund, Eight Roads Ventures, Pivotal Life Sciences
Markets: Neuroscience, Pharmaceuticals
HQ: San Diego, California, United States
Founded: 2019
Website: https://engrail.com/
LinkedIn: https://www.linkedin.com/company/engrail-therapeutics
Twitter: https://twitter.com/engrail_tx
Crunchbase: https://www.crunchbase.com/organization/engrail-therapeutics
Leave a Comment
Comments
No comments yet.